| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 3, Issue 1 43-52, Copyright © 1992 by American Association of Cancer Research
ARTICLES |
PM O'Connor, DK Ferris, GA White, J Pines, T Hunter, DL Longo and KW Kohn
National Cancer Institute, NIH, Bethesda, Maryland 20892.
M phase-promoting factor (MPF) consists of a p34cdc2 (cdc2) kinase and cyclin B complex which in its active form promotes G2 to M transition. The role of MPF in G2 arrest following DNA damage, however, has remained largely uncharacterized. We have investigated whether nitrogen mustard (HN2) interfered with either the formation of MPF or its activation. For this purpose, we measured cdc2 kinase activity relative to cdc2 and cyclin B protein turnover and the phosphorylation status of cdc2. Studies were performed in two exceptional human lymphoma cell lines, which differed in HN2 sensitivity by 5-fold (CA46, 50% growth-inhibitory dose = 1.0 microM; JLP119, 50% growth-inhibitory dose = 0.2 microM) but exhibited virtually identical DNA interstrand and DNA-protein cross-link exposure. Following HN2 treatment, CA46 cells ceased to enter mitosis and exhibited a marked delay in G2 phase. Failure to enter mitosis paralleled inhibition of cdc2 kinase. Inhibition was not due to decreased levels of cdc2 or cyclin B protein; rather, G2 arrest correlated with the accumulation of both tyrosine-phosphorylated cdc2 and cyclin B. These findings implied that G2 arrest resulted from a down-regulation of the processes that activate MPF. We also found that JLP119 cells, within a few hours of mitosis at the time of drug treatment, evaded checkpoint control and continued cell division unabated by DNA damage. Furthermore, despite similar DNA cross-link exposure, JLP119 cells within the window of checkpoint control were more susceptible to S phase delay than CA46 cells. Altered cell cycle responses correlated with the greater susceptibility of JLP119 cells to the cytotoxic effects of HN2.
This article has been cited by other articles:
![]() |
J. Kuang, G. He, Z. Huang, A. R. Khokhar, and Z. H. Siddik Bimodal Effects of 1R,2R-Diaminocyclohexane(trans-diacetato)(dichloro)platinum(IV) on Cell Cycle Checkpoints Clin. Cancer Res., November 1, 2001; 7(11): 3629 - 3639. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Janss, A. Maity, C.-B. Tang, R. J. Muschel, W. G. McKenna, L. Sutton, and P. C. Phillips Decreased cyclin B1 expression contributes to G2 delay in human brain tumor cells after treatment with camptothecin Neuro-oncol, January 1, 2001; 3(1): 11 - 21. [Abstract] [PDF] |
||||
![]() |
L. M. Knowles and J. A. Milner Diallyl disulfide inhibits p34cdc2 kinase activity through changes in complex formation and phosphorylation Carcinogenesis, June 1, 2000; 21(6): 1129 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Moreb, C. Maccow, M. Schweder, and J. Hecomovich Expression of Antisense RNA to Aldehyde Dehydrogenase Class-1 Sensitizes Tumor Cells to 4-Hydroperoxycyclophosphamide In Vitro J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 390 - 396. [Abstract] [Full Text] |
||||
![]() |
G. D. Kao, W. G. McKenna, and R. J. Muschel p34Cdc2 Kinase Activity Is Excluded from the Nucleus during the Radiation-induced G2 Arrest in HeLa Cells J. Biol. Chem., December 3, 1999; 274(49): 34779 - 34784. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. JORQUERA and R. M. TANGUAY Cyclin B-dependent kinase and caspase-1 activation precedes mitochondrial dysfunction in fumarylacetoacetate-induced apoptosis FASEB J, December 1, 1999; 13(15): 2284 - 2298. [Abstract] [Full Text] |
||||
![]() |
J. B. Jowett, Y.-m. Xie, and I. S. Y. Chen The Presence of Human Immunodeficiency Virus Type 1 Vpr Correlates with a Decrease in the Frequency of Mutations in a Plasmid Shuttle Vector J. Virol., September 1, 1999; 73(9): 7132 - 7137. [Abstract] [Full Text] |
||||
![]() |
T. M. Passalaris, J. A. Benanti, L. Gewin, T. Kiyono, and D. A. Galloway The G2 Checkpoint Is Maintained by Redundant Pathways Mol. Cell. Biol., September 1, 1999; 19(9): 5872 - 5881. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Thomas, M. W. Lamé, D. Morin, D. W. Wilson, and H. J. Segall Prolonged Cell-cycle Arrest Associated with Altered cdc2 Kinase in Monocrotaline Pyrrole-treated Pulmonary Artery Endothelial Cells Am. J. Respir. Cell Mol. Biol., July 1, 1998; 19(1): 129 - 142. [Abstract] [Full Text] |
||||
![]() |
G. M. Kupfer, T. Yamashita, D. Naf, A. Suliman, S. Asano, and A. D. D'Andrea The Fanconi Anemia Polypeptide, FAC, Binds to the Cyclin-Dependent Kinase, cdc2 Blood, August 1, 1997; 90(3): 1047 - 1054. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Uckun, L. Tuel-Ahlgren, K. G. Waddick, X. Jun, J. Jin, D. E. Myers, R. B. Rowley, A. L. Burkhardt, and J. B. Bolen Physical and Functional Interactions between Lyn and p34[IMAGE] Kinases in Irradiated Human B-cell Precursors J. Biol. Chem., March 15, 1996; 271(11): 6389 - 6397. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |